Huma Therapeutics to use AI on disease management platform
By HME News Staff
Updated 10:07 AM CDT, Tue August 29, 2023
NEW YORK – Huma Therapeutics, a global digital health company, will use Google Cloud's generative AI (GenAI) to enhance Huma's regulated disease management platform. Huma is also exploring the use of Google's GenAI tools to support healthcare professionals (HCP) with better insights to optimize care delivery. "Huma is committed to making healthcare accessible and affordable for everyone and GenAI will play a crucial role in this equitable access,” said Dan Vahdat, Huma CEO & founder. “Our new GenAI applications will help mitigate the pressures on the healthcare workforce that exist worldwide and will reduce burnout in overworked staff. We are committed to the safe and responsible introduction of GenAI into healthcare and will ensure that Huma-ns are kept in the loop, meaning that HCPs will retain control of these health technologies." Huma's technology platform captures a range of vital signs, biomarkers and patient-reported data that are displayed on an HCP dashboard. This allows HCPs to care for many more patients than they would be able to in person, helping to alleviate workforce pressures and expand access to healthcare.
Comments